Emergent Biosolutions EBS Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's change in other assets?
- Emergent Biosolutions (EBS) reported change in other assets of $500K in Q1 2026.
- How has Emergent Biosolutions's change in other assets changed year-over-year?
- Emergent Biosolutions's change in other assets increased by 105.3% year-over-year, from -$9.5M to $500K.
- What is the long-term trend for Emergent Biosolutions's change in other assets?
- Over 2 years (2021 to 2024), Emergent Biosolutions's change in other assets has grown at a 388.3% compound annual growth rate (CAGR), from -$7.7M to -$183.6M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.